SEARCH

SEARCH BY CITATION

References

  • Amminger G. P., Berger G. E., Schafer M. R., Klier C., Friedrich M. H. and Feucht M. (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol. Psychiatry 61, 551553.
  • Arndt T. L., Stodgell C. J. and Rodier P. M. (2005) The teratology of autism. Int. J. Dev. Neurosci. 23, 189199.
  • Ashwood P. and Van de Water J. (2004) Is autism an autoimmune disease? Autoimmun. Rev. 3, 557562.
  • Aureli T., Di Cocco M. E., Capuani G., Ricciolini R., Manetti C., Miccheli A. and Conti F. (2000) Effect of long-term feeding with acetyl-l-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy. Neurochem. Res. 25, 395399.
  • Bell J. G., Sargent J. R., Tocher D. R. and Dick J. R. (2000) Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot. Essent. Fatty Acids 63, 2125.
  • Bell J. G., MacKinlay E. E., Dick J. R., MacDonald D. J., Boyle R. M. and Glen A. C. (2004) Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot. Essent. Fatty Acids 71, 201204.
  • Bertrand J., Mars A., Boyle C., Bove F., Yeargin-Allsopp M. and Decoufle P. (2001) Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108, 11551161.
  • Bicalho B., David F., Rumplel K., Kindt E. and Sandra P. (2008) Creating a fatty acid methyl ester database for lipid profiling in a single drop of human blood using high resolution capillary gas chromatography and mass spectrometry. J. Chromatogr. A 1211, 120128.
  • Brass E. P., Fennessey P. V. and Miller L. V. (1986) Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes. Biochem. J. 236, 131136.
  • Brock M. and Buckel W. (2004) On the mechanism of action of the antifungal agent propionate. Eur. J. Biochem. 271, 32273241.
  • Bu B., Ashwood P., Harvey D., King I. B., Water J. V. and Jin L. W. (2006) Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot. Essent. Fatty Acids 74, 215221.
  • Calabrese V. and Rizza V. (1999) Formation of propionate after short-term ethanol treatment and its interaction with the carnitine pool in rat. Alcohol 19, 169176.
  • Cannizzaro C., Monastero R., Vacca M. and Martire M. (2003) [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions. Neurochem. Int. 43, 917.
  • Champeil-Potokar G., Chaumontet C., Guesnet P., Lavialle M. and Denis I. (2006) Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur. J. Neurosci. 24, 30843090.
  • Chauhan A. and Chauhan V. (2006) Oxidative stress in autism. Pathophysiology. 13, 171181.
  • Chauhan A., Chauhan V., Brown W. T. and Cohen I. (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci. 75, 25392549.
  • Chow S. C., Sisfontes L., Bjorkhem I. and Jondal M. (1989) Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 24, 700704.
  • Clarke J. T. and Clark-Taylor B. E. (2004) Is autism a disorder of fatty acid metabolism? Possible dysfunction of metochondrial beta oxidation by long chain acyl-CoA dehydrogenase. Med. Hypotheses 62, 970975.
  • Coulter D. L. (1991) Carnitine, valproate, and toxicity. J. Child Neurol. 6, 714.
  • Crawley J. N. (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10, 248258.
  • Cyr D., Giguere R., Giguere Y. and Lemieux B. (2000) Determination of urinary acylcarnitines: a complementary aid for the high-risk screening of several organic acidurias using a simple and reliable GC/MS-based method. Clin. Biochem. 33, 151155.
  • DeCastro M., Nankova B. B., Shah P., Patel P., Mally P. V., Mishra R. and La Gamma E. F. (2005) Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Res. Mol. Brain Res. 142, 2838.
  • Edwards R., Peet M., Shay J. and Horrobin D. (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48, 149155.
  • Fallon J. (2005) Could one of the most widely prescribed antibiotics amoxicillin/clavulanate “augmentin” be a risk factor for autism? Med. Hypotheses 64, 312315.
  • Farooqui A. A. and Horrocks L. A. (2001) Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. Neuroscientist 7, 232245.
  • Fatemi S. H., Cuadra A. E., El Fakahany E. E., Sidwell R. W. and Thuras P. (2000) Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11, 14931496.
  • Fatemi S. H., Pearce D. A., Brooks A. I. and Sidwell R. W. (2005) Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57, 9199.
  • Filipek P. A., Juranek J., Nguyen M. T., Cummings C. and Gargus J. J. (2004) Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34, 615623.
  • Filosa J. A., Dean J. B. and Putnam R. W. (2002) Role of intracellular and extracellular pH in the chemosensitive response of rat locus coeruleus neurones. J. Physiol. 541, 493509.
  • Finegold S. M., Molitoris D., Song Y. et al. (2002a) Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35, S6S16.
  • Finegold S. M., Song Y. and Liu C. (2002b) Taxonomy-general comments and update on taxonomy of Clostridia and Anaerobic cocci. Anaerobe 8, 283285.
  • Fujita K., Nakanishi K., Sobue K., Ueki T., Asai K. and Kato T. (1998) Astrocytic gap junction blockage and neuronal Ca2+ oscillation in neuron-astrocyte cocultures in vitro. Neurochem. Int. 33, 4149.
  • Hara H., Haga S., Aoyama Y. and Kiriyama S. (1999) Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J. Nutr. 129, 942948.
  • Hartig C. (2008) Rapid identification of fatty acid methyl esters using a multidimensional gas chromatography-mass spectrometry database. J. Chromatogr. A 1177, 159169.
  • Herbert M. R., Russo J. P., Yang S., Roohi J., Blaxill M., Kahler S. G., Cremer L. and Hatchwell E. (2006) Autism and environmental genomics. Neurotoxicology 27, 671684.
  • Horrobin D. F. and Bennett C. N. (1999) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 60, 141167.
  • Horvath K., Papadimitriou J. C., Rabsztyn A., Drachenberg C. and Tildon J. T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135, 559563.
  • Hu V. W., Frank B. C., Heine S., Lee N. H. and Quackenbush J. (2006) Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics 7, 118.
  • Ingram J. L., Peckham S. M., Tisdale B. and Rodier P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22, 319324.
  • James S. J., Melnyk S., Jernigan S. et al. (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med Genet. B Neuropsychiatr. Genet. 141, 947956.
  • Juszczak G. R. and Swiergiel A. H. (2009) Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 181198.
  • Jyonouchi H., Sun S. and Itokazu N. (2002) Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46, 7684.
  • Kamitani W., Ono E., Yoshino S. et al. (2003) Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc. Natl Acad. Sci. U S A 100, 89698974.
  • Kidd P. M. (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural–functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12, 207227.
  • Kiebish M. A., Han X., Cheng H., Chuang J. H. and Seyfried T. N. (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J. Lipid Res. 49, 25452556.
  • Le Poul E., Loison C., Struyf S. et al. (2003) Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 2548125489.
  • MacFabe D. F., Cain D. P., Rodriguez-Capote K., Franklin A. E., Hoffman J. E., Boon F., Taylor A. R., Kavaliers M. and Ossenkopp K. P. (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176, 149169.
  • MacFabe D. F., Rodriguez-Capote K., Hoffman J. E. et al. (2008) A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am. J. Biochem. Biotech. 4, 146166.
  • Maurer M. H., Canis M., Kuschinsky W. and Duelli R. (2004) Correlation between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci. Lett. 355, 105108.
  • Meguid N. A., Atta H. M., Gouda A. S. and Khalil R. O. (2008) Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin. Biochem. 41, 10441048.
  • Moore H. and Grace A. A. (2002) A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology 27, 980992.
  • Morris J. S., Coombes K. R., Koomen J., Baggerly K. A. and Kobayashi R. (2005) Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics 21, 17641775.
  • Nakao S., Moriya Y., Furuyama S., Niederman R. and Sugiya H. (1998) Propionic acid stimulates superoxide generation in human neutrophils. Cell Biol. Int. 22, 331337.
  • Narita N., Kato M., Tazoe M., Miyazaki K., Narita M. and Okado N. (2002) Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52, 576579.
  • Parab S., Nankova B. B. and La Gamma E. F. (2007) Differential regulation of the tyrosine hydroxylase and enkephalin neuropeptide transmitter genes in rat PC12 cells by short chain fatty acids: concentration-dependent effects on transcription and RNA stability. Brain Res. 1132, 4250.
  • Pastural E., Ritchie S., Lu Y., Jin W., Kavianpour A., Khine Su-Myat K., Heath D., Wood P. L., Fisk M. and Goodenowe D. B. (2009) Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot. Essent. Fatty Acids 81, 253264.
  • Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney; Montreal.
  • Remblier C., Pontcharraud R., Tallineau C., Piriou A. and Huguet F. (1999) Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxidative mechanisms. Brain Res. 837, 2228.
  • Richardson A. J. (2004) Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot. Essent. Fatty Acids 70, 383390.
  • Roe R. C., Millington D. S., Maltby D. A., Bohan T. P. and Hoppel C. L. (1984) l-Carnitine enhances excretion of propoinyl coenzyme A as propionylcarnitine in propoinic acidemia. J. Clin. Invest. 73, 17851788.
  • Rorig B., Klausa G. and Sutor B. (1996) Intracellular acidification reduced gap junction coupling between immature rat neocortical pyramidal neurones. J. Physiol. 490 (pt-1), 3149.
  • Rouach N., Avignone E., Meme W., Koulakoff A., Venance L., Blomstrand F. and Giaume C. (2002) Gap junctions and connexin expression in the normal and pathological central nervous system. Biol. Cell 94, 457475.
  • Schulpis K. H., Karikas G. A., Tjamouranis J., Regoutas S. and Tsakiris S. (2001) Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia 42, 13591362.
  • Severson C. A., Wang W., Pieribone V. A., Dohle C. I. and Richerson G. B. (2003) Midbrain serotonergic neurons are central pH chemoreceptors. Nat. Neurosci. 6, 11391140.
  • Seyfried T. N. and Mukherjee P. (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr. Metab (Lond) 2, 30.
  • Sherma J. and Fried B. (2003) Handbook of Thin Layer Chromatography, pp. 635991. Marcel Dekker Inc., New York.
  • Shultz S. R., MacFabe D. F., Ossenkopp K. P., Scratch S., Whelan J., Taylor R. and Cain D. P. (2008) Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 54, 901911.
  • Shultz S. R., MacFabe D. F., Martin S., Jackson J., Taylor R., Boon F., Ossenkopp K. P. and Cain D. P. (2009) Intracerebroventricular injections of the enteric bacterial metabolic product propionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav. Brain Res. 200, 3341.
  • Simopoulos A. P. (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60, 502507.
  • Sliwinski S., Croonenberghs J., Christophe A., Deboutte D. and Maes M. (2006) Polyunsaturated fatty acids: do they have a role in the pathophysiology of autism? Neuro. Endocrinol. Lett. 27, 465471.
  • Smith I. D., Sutton M. A. and Beninger R. J. (1997) Rotational bias in intact rats following intrastriatal injections of dopaminergic drugs. Pharmacol. Biochem. Behav. 58, 431441.
  • Suzuki K., Nagao K., Tokunaga J., Katayama N. and Uyeda M. (1996) Inhibition of DNA methyltransferase by microbial inhibitors and fatty acids. J. Enzyme Inhib. 10, 271280.
  • Vancassel S., Durand G., Barthelemy C., Lejeune B., Martineau J., Guilloteau D., Andres C. and Chalon S. (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot. Essent. Fatty Acids 65, 17.
  • Vargas D. L., Nascimbene C., Krishnan C., Zimmerman A. W. and Pardo C. A. (2004) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 6781.
  • Volkmar F. R., Lord C., Bailey A., Schultz R. T. and Klin A. (2004) Autism and pervasive developmental disorders. J. Child Psychol. Psychiatry 45, 135170.
  • Wagner A. K., Bayir H., Ren D., Puccio A., Zafonte R. D. and Kochanek P. M. (2004) Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J. Neurotrauma 21, 125136.
  • Wajner M., Latini A., Wyse A. T. and Dutra-Filho C. S. (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J. Inherit. Metab. Dis. 27, 427448.
  • Wiest M. M., German J. B., Harvey D. J., Watkins S. M. and Hertz-Picciotto I. (2009) Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot. Essent. Fatty Acids 80, 221227.
  • Wu K., Wasterlain C., Sachs L. and Siekevitz P. (1990) Effect of septal kindling on glutamate binding and calcium/calmodulin-dependent phosphorylation in a postsynaptic density fraction isolated from rat cerebral cortex. Proc. Natl Acad. Sci. U S A 87, 52985302.
  • Zaffanello M., Zamboni G., Fontana E., Zoccante L. and Tato L. (2003) A case of partial biotinidase deficiency associated with autism. Child Neuropsychol. 9, 184188.
  • Zerrate M. C., Pletnikov M., Connors S. L., Vargas D. L., Seidler F. J., Zimmerman A. W., Slotkin T. A. and Pardo C. A. (2007) Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J. Pharmacol. Exp. Ther. 322, 1622.